Rhesus θ-defensin-1 (RTD-1) exhibitsin vitroandin vivoactivity against cystic fibrosis strains ofPseudomonas aeruginosa

Functional Analysis and Transcriptomic Profiling of iPSC-Derived Macrophages and Their Application in Modeling Mendelian Disease

(2015) H. Zhang et al.   CIRCULATION RESEARCH

The challenges of developing effective anti-inflammatory agents in cystic fibrosis

(2015) Scott D. Sagel   Journal of Cystic Fibrosis

Conditions Associated with the Cystic Fibrosis Defect Promote ChronicPseudomonas aeruginosaInfection

(2014) Benjamin J. Staudinger et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia

(2014) S. Fiorcari et al.   HAEMATOLOGICA

Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides

(2014) Sibel Dosler et al.   PEPTIDES

Antimicrobial Peptide GL13K Is Effective in Reducing Biofilms of Pseudomonas aeruginosa

(2013) Helmut Hirt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa

(2013) Kenneth P Tai et al.   Innate Immunity

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia

(2012) Arianna Pompilio et al.   BMC MICROBIOLOGY

θ-Defensins: Cyclic Peptides with Endless Potential: FIGURE 1.

(2012) Robert I. Lehrer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Response of CFTR-Deficient Mice to Long-Term chronic Pseudomonas aeruginosa Infection and PTX3 Therapy

(2012) Moira Paroni et al.   JOURNAL OF INFECTIOUS DISEASES

Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis

(2012) Justin B. Schaal et al.   PLoS One

Humanized θ-Defensins (Retrocyclins) Enhance Macrophage Performance and Protect Mice from Experimental Anthrax Infections

(2011) S. Welkos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients

(2011) Amanda K. Miller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms

(2011) Rinki Kapoor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients

(2011) Samuel M. Moskowitz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Murine models of acute and chronic lung infection with cystic fibrosis pathogens

(2010) Alessandra Bragonzi   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities

(2010) Prasad Tongaonkar et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Design, assembly, and validation of a nose-only inhalation exposure system for studies of aerosolized viable influenza H5N1 virus in ferrets

(2010) Richard S. Tuttle et al.   Virology Journal

Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals

(2008) David J. Alexander et al.   INHALATION TOXICOLOGY